List view / Grid view
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Research coordinated by Karolinska Institutet have identified a link between defective sucrase-isomaltase gene variants and irritable bowel syndrome...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Proteros has entered into a second research agreement with Merck aimed at developing small molecule compounds against an additional epigenetic target...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Hokkaido University researchers have developed a spinal symmetry-recognition system that can 3-dimensionally detect early stages of idiopathic scoliosis...
21 November 2016 | By Dr Nick Thompson, Holisticvet Consultancy
Holistic Vet Dr Nick Thompson explains how over use of worming treatment has lead to epidemic resistance affecting up to 40% of UK children...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at the University of Oxford have been working with two major EU-funded projects to deliver a novel antibiotic programme for clinical development...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Five European research institutions have come together in recognition of the need to advance knowledge on the pathophysiology of psoriatic arthritis...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The project will analyse the genome and all expressed genes of tumour cells from 250 breast cancer patients to improve diagnosis and tailor treatment...
17 November 2016 | By Pharma Parallel Trade
Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Cell Medica has expanded its partnership with Baylor College of Medicine to develop an off-the-shelf allogeneic cell therapy, using T (NKT) cells...
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In the past, insoles for patients with diabetes were hand-made by orthopaedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically…
11 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Heptares Therapeutics and Jitsubo have entered into a collaboration to develop peptide candidates designed to target severe gastrointestinal disorders...
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer...
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the National Cancer Research...
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
BenevolentAI, a British artificial intelligence company has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen...
